Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

16 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   Calcium   Calcium   -   -   -   [24]
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 2   Calcium gluconate   Calcium gluconate   D00935   -   -   [3]
214,
215,
235 
 3   Coenzyme q10   Ubidecarenone   D01065   -   -   [10]
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 4   Dexmedetomidine   Dexmedetomidine   D00514, D01205   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [11]
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 5   Dexmedetomidine and fentanyl   Dexmedetomidine   D00514, D01205   [3] ADRA2A, ADRA2B, ADRA2C   [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   [1]
215 
 6   Dobutamine   Dobutamine   D00632, D03879, D03880, D03881   [1] ADRB1   [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   [3]
57,
58,
215 
 7   Eplerenone   Eplerenone   D01115   [1] NR3C2   [1] Aldosterone-regulated sodium reabsorption   [3]
75,
113,
215 
 8   Fentanyl   Fentanyl   D00320, D01399   [1] OPRM1   [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   [5]
46,
70,
85,
215,
231 
 9   Fluorescite   Fluorescein   D01261, D02024   -   -   [1]
215 
 10   Ketamine   Ketamine   D00711, D08098   [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   [17] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   [5]
13,
70,
113,
156,
215 
 11   Losartan   Losartan   D00357, D08146   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [18]
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 12   Losartan potassium   Potassium   D08403   -   -   [4]
98,
167,
179,
215 
 13   Potassium   Potassium   D08403   -   -   [9]
46,
66,
67,
98,
115,
167,
179,
215,
235 
 14   Recombinant human brain natriuretic peptide (rhbnp)   -   -   -   -   [1]
215 
 15   Sodium citrate   Sodium citrate   D01781, D05855   -   -   [3]
214,
215,
235 
 16   Tranexamic acid   Tranexamic acid   D01136   [1] PLG   [4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection   [5]
46,
70,
215,
227,
288